Literature DB >> 20521158

Cryptosporidiosis: environmental, therapeutic, and preventive challenges.

S Collinet-Adler1, H D Ward.   

Abstract

Cryptosporidium spp. are responsible for endemic and epidemic disease worldwide. Clinical manifestations may include acute, persistent, or chronic diarrhea, biliary, and pulmonary disease. Disease severity ranges from asymptomatic or mild to severe, intractable diarrhea with wasting depending on immune status, nutrition, and age. Transmission is fecal-oral with both human and animal reservoirs. Disease is often self limited in healthy individuals, but therapy remains a challenge in the immune-compromised. Prevention currently depends on appropriate hygiene and proper water management and treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20521158      PMCID: PMC4049176          DOI: 10.1007/s10096-010-0960-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  113 in total

Review 1.  Cryptosporidiosis.

Authors:  Xian-Ming Chen; Janet S Keithly; Carlos V Paya; Nicholas F LaRusso
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

2.  Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-gamma knockout mice.

Authors:  Pablo C Okhuysen; Stephen M Rich; Cynthia L Chappell; Kevin A Grimes; Giovanni Widmer; Xiaochuan Feng; Saul Tzipori
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

3.  Quantitation of Cryptosporidium parvum infection in cell culture using a colorimetric in situ hybridization assay.

Authors:  P A Rochelle; D M Ferguson; A M Johnson; R De Leon
Journal:  J Eukaryot Microbiol       Date:  2001 Sep-Oct       Impact factor: 3.346

4.  Serological evidence of endemic waterborne cryptosporidium infections.

Authors:  Floyd J Frost; Tim Muller; Gunther F Craun; William B Lockwood; Rebecca L Calderon
Journal:  Ann Epidemiol       Date:  2002-05       Impact factor: 3.797

Review 5.  Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients.

Authors:  Paul R Hunter; Gordon Nichols
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection.

Authors:  P Robinson; P C Okhuysen; C L Chappell; D E Lewis; I Shahab; S Lahoti; A C White
Journal:  Cytokine       Date:  2001-07-07       Impact factor: 3.861

7.  The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.

Authors:  N J Ives; B G Gazzard; P J Easterbrook
Journal:  J Infect       Date:  2001-02       Impact factor: 6.072

8.  Epidemiology of Cryptosporidium spp. and Giardia duodenalis on a dairy farm.

Authors:  R E Huetink; J W van der Giessen; J P Noordhuizen; H W Ploeger
Journal:  Vet Parasitol       Date:  2001-12-03       Impact factor: 2.738

9.  Cryptosporidium and Giardia: treatment options and prospects for new drugs.

Authors:  Jean-François Rossignol
Journal:  Exp Parasitol       Date:  2009-07-24       Impact factor: 2.011

10.  High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial.

Authors:  Beatrice Amadi; Mwiya Mwiya; Sandie Sianongo; Lara Payne; Angela Watuka; Max Katubulushi; Paul Kelly
Journal:  BMC Infect Dis       Date:  2009-12-02       Impact factor: 3.090

View more
  22 in total

1.  Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in Bangladesh.

Authors:  Anoli J Borad; Geneve M Allison; David Wang; Sabeena Ahmed; Mohammad M Karim; Anne V Kane; Joy Moy; Patricia L Hibberd; Sitara Swarna Rao Ajjampur; Gagandeep Kang; Stephen B Calderwood; Edward T Ryan; Elena Naumova; Wasif A Khan; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  Systemic and Mucosal Immune Responses to Cryptosporidium-Vaccine Development.

Authors:  Jacob G Ludington; Honorine D Ward
Journal:  Curr Trop Med Rep       Date:  2015-09-01

3.  Antibody responses to the immunodominant Cryptosporidium gp15 antigen and gp15 polymorphisms in a case-control study of cryptosporidiosis in children in Bangladesh.

Authors:  Genève M Allison; Kathleen A Rogers; Anoli Borad; Sabeena Ahmed; Mohammad Mahbubul Karim; Anne V Kane; Patricia L Hibberd; Elena N Naumova; Stephen B Calderwood; Edward T Ryan; Wasif A Khan; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

4.  Risk factors for cryptosporidiosis among children in a semi urban slum in southern India: a nested case-control study.

Authors:  Rajiv Sarkar; Deepthi Kattula; Mark R Francis; Sitara S R Ajjampur; Ashok D Prabakaran; Nithya Jayavelu; Jayaprakash Muliyil; Vinohar Balraj; Elena N Naumova; Honorine D Ward; Gagandeep Kang
Journal:  Am J Trop Med Hyg       Date:  2014-10-20       Impact factor: 2.345

5.  Identification of a family of four UDP-polypeptide N-acetylgalactosaminyl transferases in Cryptosporidium species.

Authors:  Boguslaw S Wojczyk; Maria DeCicco; Najma Bhat; Carlos Castrodad; Steven L Spitalnik; Honorine D Ward
Journal:  Mol Biochem Parasitol       Date:  2013-08-13       Impact factor: 1.759

6.  Environmental Factors Associated with High Fly Densities and Diarrhea in Vellore, India.

Authors:  Stefan Collinet-Adler; Sudhir Babji; Mark Francis; Deepthi Kattula; Prasanna Samuel Premkumar; Rajiv Sarkar; Venkat Ragava Mohan; Honorine Ward; Gagandeep Kang; Vinohar Balraj; Elena N Naumova
Journal:  Appl Environ Microbiol       Date:  2015-06-26       Impact factor: 4.792

7.  Intranasal vaccination in mice with an attenuated Salmonella enterica Serovar 908htr A expressing Cp15 of Cryptosporidium: impact of malnutrition with preservation of cytokine secretion.

Authors:  James K Roche; Ana Lara Rojo; Lourrany B Costa; Ronald Smeltz; Patricio Manque; Ute Woehlbier; Luther Bartelt; James Galen; Gregory Buck; Richard L Guerrant
Journal:  Vaccine       Date:  2012-12-16       Impact factor: 3.641

Review 8.  Burden of disease from cryptosporidiosis.

Authors:  Debbie-Ann T Shirley; Shannon N Moonah; Karen L Kotloff
Journal:  Curr Opin Infect Dis       Date:  2012-10       Impact factor: 4.915

9.  Identification and characterization of Cryptosporidium parvum Clec, a novel C-type lectin domain-containing mucin-like glycoprotein.

Authors:  Seema Bhalchandra; Jacob Ludington; Isabelle Coppens; Honorine D Ward
Journal:  Infect Immun       Date:  2013-07-01       Impact factor: 3.441

10.  Spatiotemporal analysis of Cryptosporidium species/genotypes and relationships with other zoonotic pathogens in surface water from mixed-use watersheds.

Authors:  Graham Wilkes; Norma J Ruecker; Norman F Neumann; Victor P J Gannon; Cassandra Jokinen; Mark Sunohara; Edward Topp; Katarina D M Pintar; Thomas A Edge; David R Lapen
Journal:  Appl Environ Microbiol       Date:  2012-11-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.